Mark J. Alles Buys 3260 Shares of Celgene Co. (NASDAQ:CELG) Stock

Henrietta Strickland
February 23, 2018

Cambiar Investors Llc bought 1.40 million shares as the company's stock declined 7.89% while stock markets rallied. The institutional investor held 2,702 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $394.01M, down from 2,802 at the end of the previous reported quarter. Amf Pensionsforsakring Ab who had been investing in Citizens Finl Group Inc for a number of months, seems to be bullish on the $22.64B market cap company. The stock decreased 0.04% or $0.04 during the last trading session, reaching $96.1. The Synovus Financial Corp holds 52,860 shares with $7.72 million value, down from 55,271 last quarter. About shares traded. AMCON Distributing Company (DIT) has risen 33.62% since February 15, 2017 and is uptrending. It has outperformed by 34.26% the S&P500.

Synovus Financial Corp decreased Celgene Corp (CELG) stake by 4.36% reported in 2017Q3 SEC filing. Uss Investment Management Ltd sold 140,000 shares as the company's stock declined 3.49% while stock markets rallied. About 2.21 million shares traded.

Celgene (NASDAQ:CELG) last announced its quarterly earnings results on Thursday, January 25th. It has outperformed by 0.30% the S&P500. Therefore 48% are positive. Celgene Corporation had 132 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has "Buy" rating by Jefferies given on Thursday, September 14. Piper Jaffray maintained it with "Hold" rating and $100.0 target in Thursday, December 21 report. The firm has "Buy" rating given on Monday, January 8 by Stifel Nicolaus. BMO Capital Markets maintained Celgene Corporation (NASDAQ:CELG) rating on Tuesday, October 17. Raymond James maintained the stock with "Buy" rating in Friday, December 1 report. Texas-based Sunbelt Inc has invested 0.81% in Celgene Corporation (NASDAQ:CELG). The firm earned "Hold" rating on Friday, October 27 by JMP Securities. The firm has "Buy" rating by Mizuho given on Monday, February 5. (NYSE:IT) has "Buy" rating given on Tuesday, November 10 by Cantor Fitzgerald. On Wednesday, January 24 the stock rating was maintained by SunTrust with "Buy".

Since September 5, 2017, it had 1 buy, and 3 insider sales for $2.54 million activity. The insider Curran Terrie sold 1,727 shares worth $248,498. The insider KAPLAN GILLA sold $1.31 million.

Investors sentiment increased to 1.35 in Q3 2017. The company has a market cap of $72,310.00, a P/E ratio of 26.63, a P/E/G ratio of 0.65 and a beta of 1.49. It is positive, as 56 investors sold C shares while 400 reduced holdings.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. 550.02 million shares or 0.12% less from 550.70 million shares in 2017Q2 were reported. Shell Asset Mngmt invested 0.27% of its portfolio in Celgene Corporation (NASDAQ:CELG). 61,154 are owned by Old Bancorp In. Boston Private Wealth Ltd Limited Liability Company reported 278,003 shares.

Among new and sold out positions, 179 holders initiated new positions by a total of 8.22 million shares and 199 holders exited their positions by a total of 11.62 million shares. (NASDAQ:GNMK). Fil Limited accumulated 438,785 shares. D E Shaw And Co holds 1.67 million shares or 0.37% of its portfolio. The firm owned 33,396 shares of the biopharmaceutical company's stock after selling 3,852 shares during the quarter. Banque Pictet & Cie stated it has 682,480 shares or 2.25% of all its holdings. Warren Averett Asset Management Limited reported 0.11% in Celgene Corporation (NASDAQ:CELG). During the same period in the prior year, the business posted $1.61 earnings per share. research analysts forecast that Celgene Co. will post 7.68 earnings per share for the current year.

Tiger Management Llc, which manages about $799.15M and $552.72 million US Long portfolio, upped its stake in Jpmorgan Chase & Co (NYSE:JPM) by 64,800 shares to 239,600 shares, valued at $22.88 million in 2017Q3, according to the filing. It also reduced its holding in China Mobile Limited (NYSE:CHL) by 1.03M shares in the quarter, leaving it with 2.93 million shares, and cut its stake in Umpqua Hldgs Corp (NASDAQ:UMPQ). (NYSE:C). Ig Mgmt has invested 1.2% in Citigroup Inc. Its up 0.02, from 0.68 in 2017Q2. It dropped, as 26 investors sold IT shares while 114 reduced holdings. The fund owned 117,188 shares of the biopharmaceutical company's stock after acquiring an additional 15,165 shares during the period. Amica Mutual holds 0.3% or 45,629 shares. Boston Advisors Lc invested in 324,051 shares. Granite Prns Llc has 0.05% invested in GenMark Diagnostics, Inc. (NASDAQ:AAPL). Baxter Bros owns 5,700 shares. Swiss Retail Bank invested 0% of its portfolio in GenMark Diagnostics, Inc. Clarivest Asset Limited Liability Corporation owns 0.04% invested in Titan International, Inc. Cullinan Associates Inc. now owns 64,318 shares of the biopharmaceutical company's stock valued at $8,353,000 after buying an additional 2,000 shares during the period. Lenox Wealth Mngmt holds 374 shares. Shares for $17,086 were sold by Stier Eric on Monday, August 21. Cahill Fincl Advsr holds 2,034 shares. Highstreet Asset Management Inc. increased its position in Celgene by 6.4% during the 2nd quarter. (NASDAQ:AAPL). Armstrong Henry H Assoc Inc has 0.55% invested in Apple Inc. (NASDAQ:GNMK) shares. Williams Jennifer Anne sold 365 shares worth $1,872. Kj Harrison And Ptnrs holds 3.34% of its portfolio in Apple Inc. (NASDAQ:GNMK) for 10,000 shares.

Among 5 analysts covering Titan International Inc. (NYSE:C) has "Buy" rating given on Sunday, August 13 by Keefe Bruyette & Woods. MPLX LP had 59 analyst reports since October 20, 2015 according to SRatingsIntel. The rating was maintained by PiperJaffray with "Overweight" on Wednesday, October 26. Canaccord Genuity maintained it with "Buy" rating and $156 target in Friday, November 6 report. Needham maintained the stock with "Buy" rating in Monday, June 12 report. Jefferies has "Buy" rating and $134 target. The stock has "Buy" rating by Piper Jaffray on Friday, August 25. (NASDAQ:GNMK) rating on Wednesday, February 24. Bernstein has "Outperform" rating and $160 target. The rating was maintained by Wedbush with "Outperform" on Wednesday, August 17.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Other reports by Click Lancashire

Discuss This Article

FOLLOW OUR NEWSPAPER